Ric Pierce (he/his)
@Pierce_Vasc_Lab
Followers
857
Following
3K
Media
75
Statuses
4K
Pediatric intensivist and vascular biologist passionate about MedEd, mentoring and DEI. Working to understand the vascular response to acute critical illness.
Joined May 2021
I support the Bethesda Declaration. Read about it 👇.
0
0
2
RT @elena_wilsonnn: Thankful for the opportunity to have shared great work from @Pierce_Vasc_Lab @YaleVBTProgram in Boston at @ShockSociety….
0
1
0
0
0
0
RT @LizaKonnikova: In utero human intestine contains maternally derived bacterial metabolites. Thrilled to share our latest work. Congrats….
0
12
0
RT @APSPhysiology: #APS2025 attendees: Day 1! You should have gotten your first News Update daily email with program highlights. Use the Su….
0
6
0
An excellent @YaleVBTProgram talk about endothelial cell metabolism and energetics in acute lung injury by @RebeccaFHough !!
0
1
8
RT @NIH: NIH researchers discovered that a new form of personalized cancer immunotherapy dramatically improved the treatment’s effectivenes….
0
62
0
RT @YaleVBTProgram: Congratulations to our own Angeliki Gkafyllia who matched in Pediatrics @stonybrooku !!!! We are soo happy for you! @Y….
0
1
0
RT @PeterHotez: I'm excited about my visit to @YaleSPH @Yale in April to receive the C.E.A. Winslow Medal in public health, and the opportu….
0
29
0
RT @j_g_allen: In fiscal year 2024, the report found, NIH awarded more than $36.9 billion to researchers, supporting more than 408,000 jobs….
0
396
0
RT @corynnkasap: Beautiful day and amazing turnout to hear keynote speaker and Nobel laureate Carolyn Bertozzi speak in San Francisco at to….
0
49
0
RT @StHilaireLab: On Tuesday I received the NOA (notice of award) for an @nih_nhlbi R01 grant submitted back in Feb 2024 and marked pending….
0
37
0
RT @worldheartfed: Cardiovascular disease is responsible for 30% of deaths in women each year—more than all cancers combined. Yet, heart d….
0
31
0
RT @PVRI: Happy International Women's Day!💜.At PVRI we are committed to gender equality across our leadership, events and research. We are….
0
3
0